In a prior study of [108] Persigehl et al., an NGR-based fusion protein containing the soluble mutant form of thrombogenic human tissue factor (truncated TF, tTF) was constructed for tumor growth inhibition (shown in Table 3) [108]. This evidence concerns the gene RHOH and neoplasm.